FOXD1 might be promising new diagnostic marker. »
03/22/21

Alternative factors seem to have greater contribution. »
02/09/21

Combination of 10 biomarkers outperformed any single biomarker. »
02/19/21

MMB prevalence and type of co-occurring conditions also varied by cancer type. »
04/14/21

DEspR-inhibition blocks transperitoneal dissemination and progression. »
04/14/21

Only women diagnosed in weeks 2–8 of 2020 experienced treatment delays. »
04/17/21

Significant differences for expression of CCR5, CCR6 and CD16. »
04/17/21

Effects limited to hormone receptor-positive BC. »
04/17/21

Incident VFs identified in 19.0% of all patients at 12 months after starting ADT. »
04/17/21

Inverse correlation between IκBα, oxidative metabolism, and ROS production in lung cancer. »
04/16/21